Join the 200th Anniversary Celebration

Correspondence

Anaphylaxis from Inulin in Vegetables and Processed Food

N Engl J Med 2000; 342:1372May 4, 2000

Article

To the Editor:

Inulin is a fructan and storage carbohydrate found in more than 36,000 kinds of plants, including chicory, artichokes, and salsify. Inulin has been used as a food ingredient for many years, but it is only recently that the use of inulin and oligofructose, a hydrolysate of inulin, has increased considerably owing to their many postulated health benefits and their documented properties, such as a dietary-fiber effect and their ability to increase the levels of certain enteric bacteria, including bifidobacteria.1 These fructans are now being added to an increasing number of industrially processed foods, such as candies, beverages, yogurts, ice cream, chocolate, butter, and breakfast cereals.

We describe a 39-year-old butcher who had four episodes of anaphylaxis (generalized wheal-and-flare reaction, laryngeal edema, nasal itching, cough, and breathing difficulties) a few minutes after the ingestion of salsify, artichoke leaves, a margarine (Brunch, Migros, Geneva) containing inulin extracted from chicory (Raftiline HP, Orafti, Tienen, Belgium), and a candy (Actilife Toffee orange–carrot, Migros) containing inulin (Raftiline HP) or oligofructose (Raftilose P95). He also had local wheal-and-flare reactions after touching artichokes. All four episodes occurred within a two-year period.

Skin-prick testing, in which the lancet is first stuck in the material suspected of causing immediate hypersensitivity and then into the patient's skin, disclosed a very strong reaction (diameter of wheal, 12 by 20 mm) to inulin (Raftiline HP) and strong reactions to salsify, artichoke, a margarine containing inulin (Brunch), candy (Actilife Toffee), and oligofructose (Raftilose P95). The reactions to intradermally injected undiluted inulin for tests of renal function (Inutest 25%) and oligofructose (Raftilose P95) were strongly positive. The results of skin-prick tests with inulin extract (Raftiline HP) in 10 control subjects and intradermal tests with Inutest 25% and oligofructose (Raftilose P95) in 3 controls were negative. In a double-blind, placebo-controlled food challenge, generalized urticaria, rhinoconjunctivitis, and a 20 percent drop in the peak expiratory flow rate occurred within 10 minutes after the ingestion of 10 g of inulin (Raftiline HP) in mint syrup containing rice flour, but not after the ingestion of mint syrup containing rice flour alone. The patient received 8 mg of acrivastine, and the symptoms regressed. An open oral challenge with 40 g of oligofructose (Raftilose P95) was negative in the patient.

Inulin and oligofructose are classified as food ingredients (not as additives) and are considered to be safe to eat. The labeling laws of most countries require the declaration of inulin and oligofructose in processed foods. We are unaware of other reports of anaphylaxis from inulin, including inulin used for renal-clearance studies, but because of its expanding use in processed foods, allergic reactions to this dietary ingredient may be or may become more frequent than currently recognized. The identification of an association with allergic reactions to natural foods with high inulin content or to inulin with a high degree of polymerization may provide a lead in such cases.

Fabienne Gay-Crosier, M.D.
University Hospital, CH-1211 Geneva 14, Switzerland

Georges Schreiber, M.D.
9, rue F. David, F-74100 Annemasse, France

Conrad Hauser, M.D.
University Hospital, CH-1211 Geneva 14, Switzerland

1 References
  1. 1

    Nutritional and health benefits of inulin and oligofructose: proceedings of a conference, Bethesda, Maryland, USA, May 18-19, 1998. J Nutr 1999;129:Suppl:1395S-1502S
    Web of Science | Medline

Citing Articles (11)

Citing Articles

  1. 1

    Jamile B. Taheri, Somayyeh Azimi, Nasrin Rafieian, Hosein Akhavan Zanjani. (2011) Herbs in dentistry. International Dental Journalno-no
    CrossRef

  2. 2

    Virginie Doyen, Virginie Leduc, Claire Ledent, Olivier Michel, Michel Mairesse. (2011) Allergy to jerusalem artichoke due to immediate IgE reaction to Bet v1–like allergen. Annals of Allergy, Asthma & Immunology
    CrossRef

  3. 3

    Damien Paineau, Yoram Bouhnik, Frédérique Respondek. 2009. Inulin and Oligosaccharides. .
    CrossRef

  4. 4

    Justine Bacchetta, Florence Villard, Thierry Vial, Laurence Dubourg, Raymonde Bouvier, Behrouz Kassaï, Pierre Cochat. (2008) ‘Renal hypersensitivity’ to inulin and IgA nephropathy. Pediatric Nephrology 23:10, 1883-1885
    CrossRef

  5. 5

    Justine Bacchetta, Pierre Cochat, Florence Villard, Muriel Astier, Thierry Vial, Laurence Dubourg, Aoumeur Hadj-Aissa, Behrouz Kassaï. (2008) Hypersensitivity to Inulin: A Rare and Mostly Benign Event. American Journal of Kidney Diseases 52:3, 632-633
    CrossRef

  6. 6

    Gérard Pascal. 2008. Prebiotics and Food Safety. , 449-470.
    CrossRef

  7. 7

    2007. Value in Human and Animal Diets. , 97-125.
    CrossRef

  8. 8

    Johannes Pill, Bettina Kraenzlin, Julia Jander, Tim Sattelkau, Maliha Sadick, Hans-Martin Kloetzer, Carsten Deus, Uwe Kraemer, Norbert Gretz. (2005) Fluorescein-labeled sinistrin as marker of glomerular filtration rate. European Journal of Medicinal Chemistry 40:10, 1056-1061
    CrossRef

  9. 9

    P. Franck, D.A. Moneret-Vautrin, M. Morisset, G. Kanny, M.L. Mégret-Gabeaux, J.L. Olivier. (2005) Anaphylactic Reaction to Inulin: First Identification of Specific IgEs to an Inulin Protein Compound. International Archives of Allergy and Immunology 136:2, 155-158
    CrossRef

  10. 10

    Carlo Agostoni, Irene Axelsson, Olivier Goulet, Berthold Koletzko, Kim F. Michaelsen, John W. L. Puntis, Jacques Rigo, Raanan Shamir, Hania Szajewska, Dominique Turck. (2004) Prebiotic Oligosaccharides in Dietetic Products for Infants: A Commentary by the ESPGHAN Committee on Nutrition. Journal of Pediatric Gastroenterology and Nutrition 39:5, 465-473
    CrossRef

  11. 11

    Susan E Tett, Carl M J Kirkpatrick, Annette S Gross, Andrew J McLachlan. (2003) Principles and Clinical Application of Assessing Alterations in Renal Elimination Pathways. Clinical Pharmacokinetics 42:14, 1193-1211
    CrossRef